347 related articles for article (PubMed ID: 9409302)
1. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
Koivisto UM; Turtola H; Aalto-Setälä K; Top B; Frants RR; Kovanen PT; Syvänen AC; Kontula K
J Clin Invest; 1992 Jul; 90(1):219-28. PubMed ID: 1634609
[TBL] [Abstract][Full Text] [Related]
5. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.
Vuorio AF; Turtola H; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3332-7. PubMed ID: 9409330
[TBL] [Abstract][Full Text] [Related]
6. [Influence of plasma lipids, APOE genotype and type of LDL receptor gene mutations on myocardial infarction in subjects with familial hypercholesterolemia].
Real JT; Ascaso JF; Chaves FJ; González C; Puig O; Armengod ME; Carmena R
Med Clin (Barc); 2002 May; 118(18):681-5. PubMed ID: 12042130
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction.
Koivisto UM; Hämäläinen L; Taskinen MR; Kettunen K; Kontula K
J Lipid Res; 1993 Feb; 34(2):269-77. PubMed ID: 8429261
[TBL] [Abstract][Full Text] [Related]
8. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
9. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population.
Lahtinen AM; Havulinna AS; Jula A; Salomaa V; Kontula K
Atherosclerosis; 2015 Jan; 238(1):64-9. PubMed ID: 25437892
[TBL] [Abstract][Full Text] [Related]
11. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
12. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
13. "Finnish" mutations in LDL receptor gene: a rare cause of familial hypercholesterolemia in St. Petersburg and Petrozavodsk.
Komarova TY; Golovina AS; Grudinina NA; Zakharova FM; Korneva VA; Lipovetskii BM; Serebrenitskaya MP; Konstantinov VO; Vasilyev VB; Mandelshtam MY
Bull Exp Biol Med; 2013 Jul; 155(3):380-3. PubMed ID: 24137609
[TBL] [Abstract][Full Text] [Related]
14. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
[TBL] [Abstract][Full Text] [Related]
15. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
17. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
[TBL] [Abstract][Full Text] [Related]
18. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
19. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
